Longevity Biotech Stocks Gain as Healthcare Shift Toward Cell Restoration Presents Potential Opportunity VNCE Q1 2026 Earnings EPS Surges 782 Above Estimates Stock Gains Plus500 Revenue Rises 11 in Latest Quarter Company Says It Will Meet Expectations